A limitation of this study is that the genetic instrument was for total IGF-1 levels rather than the free and bioavailable IGF-1 fraction, which may be more strongly associated with type 2 diabetes and cardiovascular diseases. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.